ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Smith & Nephew Recalls Modular SMF, Redapt Hip Implants

operating room surgical tools

UK-based medical device company Smith & Nephew announced a recall of its Modular SMF and Modular Redapt hip implants after it received reports of complaints and adverse events.

Smith & Nephew issued an Urgent Field Safety Notice on November 15, 2016 to its customers with a list of affected lots and products. The company “initiated a voluntary market removal for all lots of modular neck hip prostheses due to a higher than anticipated complaint and adverse event trend,” according to the notice.

The Modular SMF and Modular Redapt Hip System hit the market in 2008 and 2012, respectively. Both implants feature modular cobalt chrome neck pieces that fit into titanium coated metal stems. Doctors use the SMF for primary and revision hip surgery and the Redapt for revision surgery alone.

Implants affected by the recall include those shipped from October 2008 through 2016.

Metal-on-Metal Hip Design Complications

Metal-related complaints linked to the SMF and Redapt continued to increase year after year, according to the device maker. Some of the complaints associated with high metal levels in the blood include pain, soft tissue reactions and bone and tissue death — a condition also known as metallosis.

After motoring post-market performance of the two hip implants, Smith & Nephew found “patients implanted with the modular neck hip prostheses may be at greater risk of revision surgery than with comparable monolithic products.”

High metal levels associated with the SMF and Redapt could lead to complications that require revision surgery, Smith & Nephew said in its letter. But, the company only recommends surgeons proceed with revision in patients who have soft tissue reactions confirmed by blood and imaging tests.

Controversial Hip Implants Lead to Lawsuits

Injured by complications related to hip replacements? Get a Free Case Review

Metal-on-metal implants like the SMF and Redapt faced scrutiny and criticism after a number of studies found these implants cause complications related to metal debris flaking off the devices.

By 2012, the UK’s Medicines and Healthcare Products Regulatory Agency, the U.S. Food and Drug Administration and Health Canada issued medical device alerts of these hip implants.

“Reports in orthopaedic literature, data from international orthopaedic implant registries and presentations from professional/scientific meetings…have increasingly noted complications and potential problems of early failure of MoM hip systems, often requiring revision surgery,” the FDA said on its website.

Complications from metal-on-metal hip implants also led to a rash of lawsuits that led to billions of dollars in settlements and jury verdicts.

Some notable metal-on-metal hip implant settlements include:

  • Johnson & Johnson’s DePuy settled ASR hip claims for $4 billion
  • Smith & Nephew set aside $203 million for metal-on-metal hip claims
  • Biomet set aside $56 million for M2a Magnum hip claims
  • Stryker settled Rejuvenate and ABG II lawsuits for $1.4 billion
  • Wright Medical settled Conserve hip claims for $240 million

Smith & Nephew has not mentioned lawsuits for the modular SMF or Redapt, and it said this recall does not affect the monolithic versions of the implants. But, it advised doctors to continue to monitor their patients.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

2 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. U.S Food and Drug Administration. (2017, January 4). Class 2 Device Recall Modular REDAPT Hip Systems. Retrieved from
  2. FDA. (2015, April 10). Concerns about Metal-on-Metal Hip Implants. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(877) 280-3908